KRYS
Krystal Biotech, Inc.Healthcare$260.95
▲ Bullish
Mkt Cap: $7.63B|Float: 23.1M|SI: 12.5%|DTC: 9.2
Data as of market close Apr 2, 2026
IV Rank
10
IV Pctl
11%
HV 20d
34.2%
52W Range
$123-$298
ATR(14)
$10.58
Exp. Move
±7.0%
P/C Ratio
0.38
Earnings
May 4
GEX Positive
DEX Long
Net Call Premium
IV Low
Exp. Move Wide
Low Put/Call
KRYS Key Options Data
- IV Rank
- 10.3%
- Total GEX
- $0.00B
- Total DEX
- $0.2M
- Max Pain
- $260.00
- Expected Move
- ±7.0%
- Put/Call OI
- 0.38
- Net Premium
- $2.2M
- Spot Price
- $260.95
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$18.40 | ±7.0% | $242.55 | $279.35 |
| 2026-05-15 | 43 | ±$39.25 | ±15.0% | $221.70 | $300.20 |
| 2026-08-21 | 141 | ±$65.35 | ±25.0% | $195.60 | $326.30 |
| 2026-11-20 | 232 | ±$83.65 | ±32.1% | $177.30 | $344.60 |
Explore KRYS options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.